TotalMarketCap

Caris Life Sciences

CAINasdaq United StatesHealth CareMedical Specialities

Market cap

$7.491 B

$26.12 -21.37%

Close of 6 Nov 2026

As of 6 Nov 2026, Caris Life Sciences (CAI) has a market capitalization of $7.49B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$812.0M

#1633 by revenue

Earnings

-$68.1M

Loss-making

Shares outstanding

286,784,504

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Medical Specialities, ranked by market cap

All 44 →
  1. #12Oscar HealthOSCR$10.2B
  2. #13Henry ScheinHSIC$9.44B
  3. #14Caris Life SciencesCAI$7.49B
  4. #15RadNetRDNT$6.14B
  5. #16GrailGRAL$5.38B

What if Caris Life Sciences were worth as much as…

Open the what-if tool →

Gold $28.2T

$98,460.25

Per share 3,770× higher

Bitcoin $1.53T

$5,327.51

Per share 204× higher

Apple $5.02T

$17,489.73

Per share 670× higher

Or at a round number

$10.0B$20.0B$50.0B$100.0B

Where these numbers come from

Share counts and financials for Caris Life Sciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.